Singh Nitesh Kumar
Department of ICU and Anaesthesia, Tree Top Hospital, Hulhumale, Maldives.
Indian J Crit Care Med. 2022 Jul;26(7):833-835. doi: 10.5005/jp-journals-10071-24237.
The major brunt of coronavirus disease-2019 (COVID-2019) is borne by the lungs. The major cause of morbidity and mortality in COVID-19 patients is a compromise of the respiratory system. Pneumothorax is noted as an insignificant proportion of patients suffering from COVID-19, but it jeopardizes the clinical recovery significantly. We, in the case series of 10 patients, will be summarizing the epidemiological, demographic, and clinical characteristics of COVID-19 patients who also developed pneumothorax.
All the confirmed cases of COVID-19 pneumonia diagnosed between May 1, 2020 and August 30, 2020, admitted at our center meeting the inclusion criteria and whose clinical course was complicated by pneumothorax were made part of our study. Their clinical records were studied, and epidemiological, demographic, and clinical data of these patients were collected and compiled in this case series.
All the patients in our study required ICU care, and 60% received non-invasive mechanical ventilation, while 40% of the patients progressed to intubation and invasive mechanical ventilation. A total of 70% of the patients in our study had a successful outcome, while 30% succumbed to the disease and expired.
Epidemiological, demographic, and clinical characteristics of COVID-19 patients complicated with pneumothorax were evaluated. Our study showed that pneumothorax also developed in some patients who had not received mechanical ventilation, indicating that pneumothorax could be a secondary complication of SARS-CoV-2 infection. Our study also emphasizes the fact that even the majority of patients whose clinical course was complicated by pneumothorax had a successful outcome emphasizing the need for timely and adequate intervention in such cases.
Singh NK. Epidemiological and Clinical Characteristics of Adults with Coronavirus Disease 2019 Complicated with Pneumothorax. Indian J Crit Care Med 2022;26(7):833-835.
2019冠状病毒病（COVID - 2019）的主要冲击部位是肺部。COVID - 19患者发病和死亡的主要原因是呼吸系统受损。气胸在COVID - 19患者中所占比例虽小，但严重危及临床康复。在这个10例患者的病例系列中，我们将总结同时并发气胸的COVID - 19患者的流行病学、人口统计学和临床特征。
2020年5月1日至2020年8月30日期间在我们中心确诊的所有符合纳入标准且临床过程并发气胸的COVID - 19肺炎确诊病例均纳入本研究。研究他们的临床记录，并收集和整理这些患者的流行病学、人口统计学和临床数据。
我们研究中的所有患者均需要重症监护病房（ICU）护理，60%接受无创机械通气，40%的患者进展为插管和有创机械通气。我们研究中共有70%的患者预后良好，30%的患者病情恶化死亡。
评估了并发气胸的COVID - 19患者的流行病学、人口统计学和临床特征。我们的研究表明，一些未接受机械通气的患者也会发生气胸，这表明气胸可能是SARS-CoV-2感染的继发性并发症。我们的研究还强调了这样一个事实，即即使大多数临床过程并发气胸的患者预后良好，也凸显了在此类病例中及时和充分干预的必要性。
Singh NK。2019冠状病毒病成人并发气胸的流行病学和临床特征。《印度重症监护医学杂志》2022；26(7):833 - 835。
